# Clozapine

## MezaPin 100mg

| TAH Drug Code      | [OMEZ](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OMEZ)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|:-------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Schizophrenia that have failed to respond to other medications.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Dosing             | Schizophrenia: Oral: Initial: 12.5 mg once or twice daily; increase, as tolerated, in increments of 25 to 50 mg daily to a target dose of 300 to 450 mg daily (administered in divided doses) by the end of 2 weeks; may further titrate in increments not exceeding 100 mg and no more frequently than once or twice weekly. Maximum total daily dose: 900 mg. Suicidal behavior in schizophrenia or schizoaffective disorder: Oral: Initial: 12.5 mg once or twice daily; increased, as tolerated, in increments of 25 to 50 mg daily to a target dose of 300 to 450 mg daily (administered in divided doses) by the end of 2 weeks; may further titrate in increments not exceeding 100 mg and no more frequently than once or twice weekly. Mean dose is ~300 mg daily; maximum total daily dose: 900 mg.                                                                                                                                                               |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| Contraindications  | Serious hypersensitivity to clozapine or any component of the formulation. Patients with a history of drug-induced agranulocytosis or agranulocytosis, or those with myeloproliferative disorders should not use this product. Uncontrolled epilepsy. Alcoholic or toxic mental patients, drug poisoning, coma. Severe liver or kidney disease.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Adverse Effects    | Initially drowsiness, hypersalivation, granulocytopenia & agranulocytosis, palpitation, fatigue. Dry mouth, blurred vision, orthostatic hypotension, disturbance in temp regulation. Tachycardia, ECG changes. Rarely: delirium, extrapyramidal reactions. Cardiovascular: Hypotension, Tachyarrhythmia (25%) Dermatologic: Rash (2%), Sweating symptom (6%) Endocrine metabolic: Excessive salivation (31% ), Weight gain (4%) Gastrointestinal: Constipation (14% ), Excessive salivation (31% ), Nausea (5% ), Xerostomia (6% ) Musculoskeletal: Motor function behavior finding (4%), Muscle rigidity (3%) Neurologic: Akathisia (3%), Confusion (3%), Dizziness (19%), Headache (7%), Insomnia (2%), Somnolence (39%), Tremor (6%), Vertigo (19%) Ophthalmic: Visual disturbance (5%) Psychiatric: Agitation (4%), Dyssomnia, Nightmares (4%), Restlessness (4%) Other: Fatigue (2%), Fever (5%) Tachycardia, ECG changes. Rarely: delirium, extrapyramidal reactions. |
| Pregnancy          | Compatible â€“ Maternal Benefit >> Embryo-Fetal Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Lactation          | No (Limited) Human Data - Potential Toxicity                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| More Info          | [UpToDate](https://www.uptodate.com/contents/clozapine-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |

